The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.

C Zocchi, E Ongini, A Conti, A Monopoli… - … of Pharmacology and …, 1996 - ASPET
We have characterized the in vitro pharmacological profile of the new potent and selective
A2a adenosine receptor antagonist SCH 58261 [7-(2-phenylethyl)-5-amino-2-(2-furyl) …

Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine Derivatives:  Potent and Selective A2A Adenosine Antagonists

PG Baraldi, B Cacciari, G Spalluto… - Journal of medicinal …, 1996 - ACS Publications
A series of pyrazolo [4, 3-e]-1, 2, 4-triazolo [1, 5-c] pyrimidine derivatives (10a− o, q, r),
bearing alkyl and aralkyl chains on positions 7 and 8, were synthesized in the attempt to …

The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A2a selective adenosine receptor antagonist

SM Poucher, JR Keddie, P Singh… - British journal of …, 1995 - Wiley Online Library
1 This paper describes the in vitro pharmacology of ZM 241385 (4‐(2‐[7‐amino‐2‐(2‐
furyl)[1, 2, 4]‐triazolo [2, 3‐a][1, 3, 5] triazin‐5‐yl amino] ethyl) phenol), a novel non‐xanthine …

KF17837 ((E)-8-(3, 4-dimethoxystyryl)-1, 3-dipropyl-7-methylxanthine) a potent and selective adenosine A2 receptor antagonist

H Nonaka, M Ichimura, M Takeda, Y Nonaka… - European Journal of …, 1994 - Elsevier
Abstract 8-(3, 4-Dimethoxystyryl)-1, 3-dipropyl-7-methylxanthine exhibited high affinity and
selectivity for adenosine A 2A receptors in binding assay using rat striatal A 2A receptors …

Selective adenosine A2A receptor antagonists

E Ongini, A Monopoli, B Cacciari, PG Baraldi - Il Farmaco, 2001 - Elsevier
In the early 1990s it became clear that the A2A adenosine receptor had characteristics that
made it distinct from the other A1, A2B and A3 adenosine receptors. Great progress has …

Characterization of 8-(N-methylisopropyl) amino-N6-(5'-endohydroxy-endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine …

PL Martin, RJ Wysocki, RJ Barrett, JM May… - Journal of Pharmacology …, 1996 - ASPET
Previous studies in our laboratory identified N6-endonorbornyl-9-methyladenine (N-0861)
as a highly selective (100-fold) A1-adenosine receptor antagonist (KB= 500 nM). However …

[PDF][PDF] Potent adenosine receptor antagonists that are selective for the A1 receptor subtype.

EA Martinson, RA Johnson, JN Wells - Molecular pharmacology, 1987 - Citeseer
The xanthines currently represent the most potent class of adenosine receptor antagonists.
However, known derivatives of xanthine show little difference in antagonist potency between …

[HTML][HTML] Current developments of A2A adenosine receptor antagonists

PG Baraldi, B Cacciari, G Spalluto… - Current medicinal …, 1995 - books.google.com
Adenosine regulates a wide range of physiological functions f! l, _ through specific cell
membrane receptors. On the basis of pharmacological I" til, studies and molecular cloning …

Medicinal chemistry of A2A adenosine receptor antagonists.

B Cacciari, G Pastorin, G Spalluto - Current Topics in Medicinal …, 2003 - europepmc.org
Due to the clearly demonstrated receptor-receptor interaction between adenosine A (2A)
and dopamine D (2) receptors in the basal ganglia, the discovery and development of potent …

Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo [3, 4-d] pyrimidines, pyrrolo [2, 3-d] pyrimidines and 6-arylpurines

RJ Gillespie, IA Cliffe, CE Dawson, CT Dourish… - Bioorganic & medicinal …, 2008 - Elsevier
Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines,
pyrrolo[2,3-d]pyrimidines and 6-arylpurines - ScienceDirect Skip to main contentSkip to …